Nieuwe onderzoeken over suïcidepreventie binnenkort van start

ZonMw honoreert 10 onderzoeken op het gebied van suïcidepreventie. In deze onderzoeken staat een integrale aanpak en samenwerking rond suïcidepreventie centraal. Ook is er aandacht voor verschillende risicogroepen.
ZonMw: Nieuws

ZonMw en VtdK in gesprek over onderzoek naar complementaire zorg

De Vereniging tegen de Kwakzalverij (VtdK) en ZonMw voeren al enige tijd een discussie met elkaar over de vraag: of en wanneer wetenschappelijk onderzoek naar complementaire zorg (nog) zinvol is?
ZonMw: Nieuws

Preventie van overgewicht vanaf de geboorte

Hoe kunnen professionals in de Jeugdgezondheidszorg (JGZ) overgewicht bij kinderen vanaf de geboorte voorkomen? Dat is de centrale vraag in het proefschrift van Eveliene Dera-de Bie. Begin juli heeft zij haar proefschrift ‘Overweight prevention, starting from birth onwards’ verdedigd.
ZonMw: Nieuws

Investeren in GGz-onderzoek loont

Wat levert toepassing van onderzoeksresultaten in de geestelijke gezondheidszorg op? Bij 5 studies is dit onderzocht. De geschatte baten tellen op tot ruim € 2,4 miljard.
ZonMw: Nieuws

Clinical Trial Data as Public Goods: Fair Trade and the Virtual Knowledge Bank as a Solution to the Free Rider Problem – A Framework for the Promotion of Innovation by Facilitation of Clinical Trial Data Sharing among Biopharmaceutical Companies in the Era of Omics and Big Data.

  Biowebspin, June 6th, 2016

Clinical Trial Data as Public Goods: Fair Trade and the Virtual Knowledge Bank as a Solution to the Free Rider Problem – A Framework for the Promotion of Innovation by Facilitation of Clinical Trial Data Sharing among Biopharmaceutical Companies in the Era of Omics and Big Data.

by Evangelatos N, Reumann M, Lehrach H, Brand A in Public Health Genomic, 2016

Background: Knowledge in the era of Omics and Big Data has been increasingly conceptualized as a public good. Sharing of de-identified patient data has been advocated as a means to increase confidence and public trust in the results of clinical trials. On the other hand, research has shown that the current research and development model of the biopharmaceutical industry has reached its innovation capacity. In response to that, the biopharmaceutical industry has adopted open innovation practices, with sharing of clinical trial data being among the most interesting ones. However, due to the free rider problem, clinical trial data sharing among biopharmaceutical companies could undermine their innovativeness.
Method: Based on the theory of public goods, we have developed a commons arrangement and devised a model, which enables secure and fair clinical trial data sharing over a Virtual Knowledge Bank based on a web platform. Our model uses data as a virtual currency and treats knowledge as a club good.
Results:
Fair sharing of clinical trial data over the Virtual Knowledge Bank has positive effects on the innovation capacity of the biopharmaceutical industry without compromising the intellectual rights, proprietary interests and competitiveness of the latter.
Conclusion:
The Virtual Knowledge Bank is a sustainable and self-expanding model for secure and fair clinical trial data sharing that allows for sharing of clinical trial data, while at the same time it increases the innovation capacity of the biopharmaceutical industry.

  Get Full text: PDF-icon

The post Clinical Trial Data as Public Goods: Fair Trade and the Virtual Knowledge Bank as a Solution to the Free Rider Problem – A Framework for the Promotion of Innovation by Facilitation of Clinical Trial Data Sharing among Biopharmaceutical Companies in the Era of Omics and Big Data. appeared first on Biowebspin.

Biowebspin

Towards a framework for understanding transitional green entrepreneurship

  Biowebspin, June 13th, 2016

Towards a framework for understanding transitional green entrepreneurship

by Anne de Bruinab, in Small Enterprise Research, 2016

The serious and complex environmental problems confronting today’s society highlight the urgent need to effect a transition to a greener, ecologically sustainable future. This article presents a multilevel conceptual framework to advance understanding of this transition. Aligning with entrepreneurship as agency for social change, it captures the nature of transformative social change by employing different levels of social innovation (incremental, institutional and disruptive), and change (local, institutional and systemic change), associating each level with a type of social change agent, namely, green entrepreneurs or ‘ecopreneurs’. The contemporary climate of social change overlays this integrative framework. Hence the temporal context links ecopreneurial activities to their political economy, socio-technological and cultural contexts, and the intensity of social action provides momentum for scaling their impact. New Zealand examples and insights drawn from the 2014 ‘Transitional green entrepreneurs: Re-thinking ecopreneurship for the 21st century,’ Symposium, in Sweden, illuminate the framework.

  See the article and check access: PDF-iconIf you can’t access this article, do not hesitate to contact us.

The post Towards a framework for understanding transitional green entrepreneurship appeared first on Biowebspin.

Biowebspin

Open Innovation: A New Mechanism For Adoption Of Organizational Innovation Empirical Evidence From Algerian Companies

  Biowebspin, June 17th, 2016

Open Innovation: A New Mechanism For Adoption Of Organizational Innovation Empirical Evidence From Algerian Companies

by Khayra Aichouche, Rafika Bousalem, in International Journal of Innovation, 2016

The aim of this paper is to analyze the relationship between the openness degree of companies and organizational innovation. The openness degree is defined as the use of purposive inflows and outflows of knowledge to accelerate internal Innovation, and to expend markets for external use of innovation (Chesbrough, 2006). The research utilizes causality models and suggests a conceptual schema subsequent to a comprehensive analysis of the literature linked to open innovation field. A sample of 120 managers and employees of Algerian pharmaceutical company is used. The SEM is used to analyze and approve the proposal of the conceptual schema. Results of the empirical research show that open innovation is positively and significantly related to organizational innovation, on the other hand, these results indicate that there is a positive and significant impact of organizational innovation on organizational performance.

  See the article and check access: PDF-iconIf you can’t access this article, do not hesitate to contact us.

The post Open Innovation: A New Mechanism For Adoption Of Organizational Innovation Empirical Evidence From Algerian Companies appeared first on Biowebspin.

Biowebspin

Follow #eHealth2011: Measuring the Role and Effectiveness of Online and Social Media in Increasing the Outreach of a Scientific Conference

Background: Social media promotion is increasingly adopted by organizers of industry and academic events; however, the success of social media strategies is rarely questioned or the real impact scientifically analyzed. Objective: We propose a framework that defines and analyses the impact, outreach, and effectiveness of social media for event promotion and research dissemination to participants of a scientific event as well as to the virtual audience through the Web. Methods: Online communication channels Twitter, Facebook, Flickr, and a Liveblog were trialed and their impact measured on outreach during five phases of an eHealth conference: the setup, active and last-minute promotion phases before the conference, the actual event, and after the conference. Results: Planned outreach through online channels and social media before and during the event reached an audience several magnitudes larger in size than would have been possible using traditional means. In the particular case of eHealth 2011, the outreach using traditional means would have been 74 attendees plus 23 extra as sold proceedings and the number of downloaded articles from the online proceedings (4107 until October 2013). The audience for the conference reached via online channels and social media was estimated at more than 5300 in total during the event. The role of Twitter for promotion before the event was complemented by an increased usage of the website and Facebook during the event followed by a sharp increase of views of posters on Flickr after the event. Conclusions: Although our case study is focused on a particular audience around eHealth 2011, our framework provides a template for redefining “audience” and outreach of events, merging traditional physical and virtual communities and providing an outline on how these could be successfully reached in clearly defined event phases.
Journal of Medical Internet Research

3 miljoen euro voor pilot Replicatiestudies

ZonMw gaat samen met NWO Maatschappij- en Gedragswetenschappen een pilotprogramma Replicatiestudies uitvoeren. NWO trekt hiervoor 3 miljoen euro uit. Naar verwachting wordt de eerste subsidieoproep in september opengesteld.
ZonMw: Nieuws

How Affiliation Disclosure and Control Over User-Generated Comments Affects Consumer Health Knowledge and Behavior: A Randomized Controlled Experiment of Pharmaceutical Direct-to-Consumer Advertising on Social Media

Background: More people are seeking health information online than ever before and pharmaceutical companies are increasingly marketing their drugs through social media. Objective: The aim was to examine two major concerns related to online direct-to-consumer pharmaceutical advertising: (1) how disclosing an affiliation with a pharmaceutical company affects how people respond to drug information produced by both health organizations and online commenters, and (2) how knowledge that health organizations control the display of user-generated comments affects consumer health knowledge and behavior. Methods: We conducted a 2×2×2 between-subjects experiment (N=674). All participants viewed an infographic posted to Facebook by a health organization about a prescription allergy drug. Across conditions, the infographic varied in the degree to which the health organization and commenters appeared to be affiliated with a drug manufacturer, and the display of user-generated comments appeared to be controlled. Results: Affiliation disclosure statements on a health organization’s Facebook post increased perceptions of an organization-drug manufacturer connection, which reduced trust in the organization (point estimate –0.45, 95% CI –0.69 to –0.24) and other users who posted comments about the drug (point estimate –0.44, 95% CI –0.68 to –0.22). Furthermore, increased perceptions of an organization-manufacturer connection reduced the likelihood that people would recommend the drug to important others (point estimate –0.35, 95% CI –0.59 to –0.15), and share the drug post with others on Facebook (point estimate –0.37, 95% CI –0.64 to –0.16). An affiliation cue next to the commenters’ names increased perceptions that the commenters were affiliated with the drug manufacturer, which reduced trust in the comments (point estimate –0.81, 95% CI –1.04 to –0.59), the organization that made the post (point estimate –0.68, 95% CI –0.90 to –0.49), the likelihood of participants recommending the drug (point estimate –0.61, 95% CI –0.82 to –0.43), and sharing the post with others on Facebook (point estimate –0.63, 95% CI –0.87 to –0.43). Cues indicating that a health organization removed user-generated comments from a post increased perceptions that the drug manufacturer influenced the display of the comments, which negatively affected trust in the comments (point estimate –0.35, 95% CI –0.53 to –0.20), the organization (point estimate –0.31, 95% CI –0.47 to –0.17), the likelihood of recommending the drug (point estimate –0.26, 95% CI –0.41 to –0.14), and the likelihood of sharing the post with others on Facebook (point estimate –0.28, 95% CI –0.45 to –0.15). (All estimates are unstandardized indirect effects and 95% bias-corrected bootstrap confidence intervals.) Conclusions: Concern over pharmaceutical companies hiding their affiliations and strategically controlling user-generated comments is well founded; these practices can greatly affect not only how viewers evaluate drug information online, but also how likely they are to propagate the information throughout their online and offline social networks.
Journal of Medical Internet Research